Among all the dreams of living longer, there's one corner that's stranger than the rest — it isn't waiting on a lab, it isn't waiting on the FDA, it's already a real product on the shelf with real revenue. That's "NAD+ & Cellular Energetics": supplements that claim to refill the "cellular fuel" that declines with age. People buy them by the millions of bottles, and one company pulls in over $129 million a year — but here's the thing that has to be said plainly: the science is still running several steps "behind the market." These products really do raise NAD+ in your blood. But do they actually make you "age slower"? No one has proven that yet.
Contains
Theme index· base 100 · USD total return
No index history for this theme yet.
News & notes movingNAD+ & Cellular Energetics
NAD+ & Cellular Energetics2
Thai Union Ingredient Launches Longevity Portfolio from Tuna
Thai Union Ingredient (TUI) has launched its Longevity portfolio at Vitafoods Asia 2026, presenting innovative ingredient solutions derived from tuna. The portfolio includes DHA fish oil, collagen, and bio-calcium, all backed by a 100% traceability system across the entire supply chain. These three ingredients are developed from by-products of tuna processing, namely fish heads, skin, and bones, at facilities in Germany, Samut Sakhon, and Songkhla. The company aims to generate at least $30 million in revenue from ThalaCol™ within five years and to increase premium-grade omega-3 oil sales with a compound annual growth rate of over 50% by 2030.
APCO Q2/2026 Revenue 44.25 Million Baht, Expands Longevity Market with New Mylife100A Formula
APCO reported its Q2/2026 financial results with total revenue of 44.25 million baht and net profit of 11.06 million baht. The company continues to capitalize on the longevity trend by launching the new Mylife100A formula, which features anti-aging and holistic health restoration benefits. The information was provided by Professor Dr. Pichet Viriyachitra, Chief Executive Officer. The company is also expanding its consumer base through BIM Advisor. The details were disclosed at the Opportunity Day event organized by the Stock Exchange of Thailand, and the recording can be viewed at www.set.or.th/streaming/vdos-oppday.
SNPS Signals Positive Second Half with Net Profit of 44.25 Million Baht
Specialty Natural Products Public Company Limited, or SNPS, reported its operating results for the first half of 2026, with total revenue of 259.19 million baht, of which revenue from sales and services was 250.14 million baht, accounting for 96.51% of total revenue, and a net profit of 44.25 million baht, maintaining a net profit margin of 17.07%, reflecting efficient management. The company views the trends of consumers in the Longevity and Preventive Health groups as opportunities to expand its business, while elevating Thai herbs from commodities to premium products and expanding markets both domestically and internationally. This signals a positive second half, as it strives to be a leader in the production and extraction of Thai herbs to global standards.
APCO Upgrades Mylife100A with New Formula, Targets Longevity Market
APCO has launched a new formula of Mylife100A to cater to the Longevity trend, focusing on cellular health restoration and reducing the risk of dementia. The company plans to publish its research in an international academic journal by September. It will expand its customer base through BIM Advisor and is preparing to export to South Africa via partner INFINITUM GLOBAL HEALTH, with an initial order of 1,500,000 bottles in the first year. For the second quarter of 2026, the company reported total revenue of 44.25 million baht and net profit of 11.06 million baht. In the first half of the year, total revenue was 93.81 million baht and net profit was 28.95 million baht.
Anti-Aging Supplements Market Projected to Reach USD 10.65 Billion by 2035
The global anti-aging supplements market is projected to reach USD 10.65 billion by 2035, growing at a compound annual growth rate of 7.88 percent from 2026 to 2035, according to a new report by SNS Insider. The market was valued at USD 5.00 billion in 2025. North America led with approximately 37 percent of global revenue in 2025, while the Asia Pacific region is expected to record the fastest growth at an 8.39 percent CAGR. The collagen segment held the largest ingredient share at about 69.22 percent in 2025, and the capsules and tablets formulation segment dominated due to convenience and precise dosage.
BIZ Launches BIZGENES Brand with The Vitality Collection Dietary Supplements
Business Alignment, or BIZ, has launched the BIZGENES brand along with The Vitality Collection, a line of dietary supplements developed under the DNA Insight concept and science-based nutrition principles to provide holistic health care tailored to individual lifestyles. CEO Sompong Chuenkittiyanont announced at the BIZGENES Brand Launch and Medical Symposium 2026 that BIZGENES is a precision health and longevity solutions brand that integrates health science, technology, and personal data to support preventive healthcare. The business will operate both B2B with hospitals and clinics and B2C to make personalized health products and services more accessible to the public.
Inside Senolytics: The Business of Destroying Zombie Cells to Reverse Aging
The biotechnology industry for life extension is attracting funds from global billionaires. One key technology is Senolytics, the development of drugs that destroy zombie cells, which are a cause of degenerative diseases. From an investment perspective, there are two interesting groups of listed companies. The first is Unity Biotechnology, a pioneer in developing localized Senolytic drugs, such as treatments for age-related macular degeneration, with strengths in intellectual property and a network of world-class researchers. The second is ChromaDex Corporation, which holds patents and manufactures NAD+ precursors under a business model of wholesale and direct-to-consumer sales, generating stable recurring revenue. Investing in this theme should therefore diversify risk between high-risk pioneers and cash-flow-generating infrastructure players.
B.Grimm Pharma Launches EXXÉ PRO-AGE, Entering the Skincare Market
B.Grimm Pharma has launched a new skincare line, EXXÉ PRO-AGE, under the Natural Repair Intelligence innovation, building on research from the Faculty of Science at Chulalongkorn University and incorporating beauty technology from South Korea. The line aims to meet long-term skincare needs based on the concepts of Healthy Aging and Skin Longevity. Ms. Caroline Link, Co-President of B.Grimm Pharma, revealed that the company has shifted its approach from traditional anti-aging to strengthening the skin's structure from within. This product range is the result of collaboration with the research team of Professor Dr. Anchalee Tassanakajorn, who has studied skin cell regeneration from land snails for over 40 years. The products use extracts from Nuan snails and Siam snails processed under patented methods, combined with extracts from Dendrobium orchids, which are high in antioxidants. The EXXÉ PRO-AGE line includes two serum formulas: EXXÉ PRO-AGE Serum, which focuses on hydration and reducing fatigue, and EXXÉ PRO-AGE+ Serum, which adds Encapsulated Collagen Peptide and NMN to address wrinkles and sagging. Both products are now available at Watsons stores and online channels Shopee, Lazada, and TikTok Shop.
Life Extension Launches Two NMN Supplements to Boost NAD+ Levels
Life Extension has introduced two new NMN (nicotinamide mononucleotide) formulas designed to increase NAD+ levels, a coenzyme that declines with age and is vital for cellular energy. The products are NAD+ Cell Support NMN Nicotinamide Mononucleotide, a stand-alone NMN supplement, and Optimized NAD+ NMN Nicotinamide Mononucleotide with Resveratrol Elite™, which combines NMN with a highly bioavailable form of resveratrol. Research scientist Kristen Dominguez, PhD, noted that NMN is a direct precursor to NAD+ with clinical data showing it helps increase NAD+ levels in the bloodstream. The resveratrol in the combined formula uses fenugreek seed fibers to achieve 10 times greater bioavailability than traditional resveratrol, offering additional healthy aging benefits. Both formulas are available in 30- and 90-count vegetarian capsules and are non-GMO and gluten-free.